Richard Payerchin
Editor at Medical Economics
Editor at Medical Economics. Much to learn. Eager to share. And vice versa. @MedEconomics
Articles
-
1 week ago |
targetedonc.com | Richard Payerchin
Many physicians believe medicine is a team sport and with their education, training, and experience, they should be team leaders. Managing patient health is the top priority. That will go better when doctors can effectively manage the rest of the team in a medical office setting. Experts in various fields, including medical doctors and business executives, have written volumes describing the characteristics of a good leader. Those analyses are important and insightful.
-
2 weeks ago |
infectioncontroltoday.com | Richard Payerchin
This article first appeared on our sister brand, Medical Economics. Health care organizations ripped the decision to dissolve a national advisory board on vaccines, and apparently reconstitute it for a meeting this month. On June 9, Health and Human Services (HHS) Secretary Robert F. Kennedy announced he was firing 17 sitting members of the Advisory Committee for Immunization Practices (ACIP).
-
1 month ago |
infectioncontroltoday.com | Richard Payerchin
This article first appeared in our sister brand, Medical Economics®. US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr spent yesterday, May 15, 2025, in hearings with the House Appropriations Committee and the Senate Committee on Health, Education, Labor & Pensions (HELP). Physicians in Congress had a chance to inquire of Kennedy on May 14 in the Senate HELP Committee and, earlier in the day, the House Appropriations Committee.
-
1 month ago |
foodsafety.einnews.com | Richard Payerchin
Everzure, a blue food dye extracted from the algae Galdieria sulphuraria, has received approval for use by the U.S. Food and Drug Administration. This image was published on the website of the coloring creator Fermentalg. Meanwhile, FDA and the National Institutes of Health (NIH) will team up on "a new, joint innovative research initiative" devoted to analysis of ultraprocessed foods.
-
Feb 28, 2025 |
patientcareonline.com | Richard Payerchin
This interview appeared originally on partner website Medical Economics. The US may be the global leader in scientific research and medicine, but the nation and its patients are not immune to problems caused by antimicrobial resistance (AMR).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 29K
- DMs Open
- No
RT @MedEconomics: “We simply don’t have enough.” — @RepBrianFitz. New bipartisan bill would add 14,000 Medicare-funded residency slots + l…
RT @MedEconomics: “Linking payments to the actual cost of providing care is essential.” — @AmerMedicalAssn President Bobby Mukkamala, MD (@…
RT @MedEconomics: “Our medical system has been a 50-year failure.” @US_FDA's @DrMakaryFDA and @VPrasadMDMPH unveil a bold new roadmap in a…